Moreover, patients with albuminuria may benefit from guideline-recommended treatment,27 such as renin-angiotensin-system inhibitors, sodium-glucose cotransporter two inhibitors, and non-steroidal mineralocorticoid receptor antagonist, to mitigate their risks of cardiovascular and kidney diseases. Here, NR3C2 is linked to kidney disorder.